BACKGROUND: Previous studies have demonstrated that elevated pre-operative monocyte count is an independent predictor of acute neurocognitive decline following carotid endarterectomy (CEA). Monocyte chemoattractant protein-1 (MCP-1), secreted by human endothelial and monocyte-like cells, is a potent mediator of inflammation and mononuclear cell trafficking. This study examines the relationship between peri-operative serum MCP-1 elevation and post-operative neurocognitive injury following CEA. METHODS: Fifty-two patients undergoing CEA and 67 lumbar laminectomy (LL) controls were administered a battery of five neuropsychological tests pre-operatively and on post-operative day 1 (POD 1). Change in individual test scores from baseline to POD 1 were converted into Z-score and used to develop a point system quantifying the degree of neurocognitive dysfunction relative to change within the LL group. Neurocognitive injury following CEA was defined as a score greater than 2 standard deviations above mean total deficit scores of LL controls. Serum MCP-1 levels were measured pre-operatively and on POD 1 by enzyme-linked immunosorbent assay. FINDINGS: Mean percent MCP-1 elevation was higher for the 13 injured CEA patients (147.7 +/- 32.4%) in our cohort compared to 39 age- and sex-matched uninjured CEA patients (76.0 +/- 16.5%). In unconditional multivariate logistic regression analysis, percent elevation in serum MCP-1 level was associated with neurocognitive injury one day after CEA (OR = 2.19, 95% CI = 1.13-4.26, P = 0.021, for a 100% elevation from pre-operative levels). CONCLUSIONS: Peri-operative elevations in serum MCP-1 levels correlate with acute neurocognitive dysfunction following CEA. These data implicate an inflammatory mechanism in the pathogenesis of Ischaemic neurocognitive decline.
BACKGROUND: Previous studies have demonstrated that elevated pre-operative monocyte count is an independent predictor of acute neurocognitive decline following carotid endarterectomy (CEA). Monocyte chemoattractant protein-1 (MCP-1), secreted by human endothelial and monocyte-like cells, is a potent mediator of inflammation and mononuclear cell trafficking. This study examines the relationship between peri-operative serum MCP-1 elevation and post-operative neurocognitive injury following CEA. METHODS: Fifty-two patients undergoing CEA and 67 lumbar laminectomy (LL) controls were administered a battery of five neuropsychological tests pre-operatively and on post-operative day 1 (POD 1). Change in individual test scores from baseline to POD 1 were converted into Z-score and used to develop a point system quantifying the degree of neurocognitive dysfunction relative to change within the LL group. Neurocognitive injury following CEA was defined as a score greater than 2 standard deviations above mean total deficit scores of LL controls. Serum MCP-1 levels were measured pre-operatively and on POD 1 by enzyme-linked immunosorbent assay. FINDINGS: Mean percent MCP-1 elevation was higher for the 13 injured CEA patients (147.7 +/- 32.4%) in our cohort compared to 39 age- and sex-matched uninjured CEA patients (76.0 +/- 16.5%). In unconditional multivariate logistic regression analysis, percent elevation in serum MCP-1 level was associated with neurocognitive injury one day after CEA (OR = 2.19, 95% CI = 1.13-4.26, P = 0.021, for a 100% elevation from pre-operative levels). CONCLUSIONS: Peri-operative elevations in serum MCP-1 levels correlate with acute neurocognitive dysfunction following CEA. These data implicate an inflammatory mechanism in the pathogenesis of Ischaemic neurocognitive decline.
Authors: J Mocco; David A Wilson; Ricardo J Komotar; Joseph Zurica; William J Mack; Hadi J Halazun; Raheleh Hatami; Robert R Sciacca; E Sander Connolly; Eric J Heyer Journal: Neurosurgery Date: 2006-05 Impact factor: 4.654
Authors: J Mocco; David A Wilson; Andrew F Ducruet; Ricardo J Komotar; William J Mack; Joseph Zurica; Robert R Sciacca; Eric J Heyer; E Sander Connolly Journal: Stroke Date: 2005-12-01 Impact factor: 7.914
Authors: Y Furukawa; A Matsumori; N Ohashi; T Shioi; K Ono; A Harada; K Matsushima; S Sasayama Journal: Circ Res Date: 1999-02-19 Impact factor: 17.367
Authors: Eric J Heyer; Robert DeLaPaz; Hadi J Halazun; Anita Rampersad; Robert Sciacca; Joseph Zurica; Alan I Benvenisty; Donald O Quest; George J Todd; Sean Lavine; Robert A Solomon; E Sander Connolly Journal: Neurosurgery Date: 2006-03 Impact factor: 4.654
Authors: Eric J Heyer; Joanna L Mergeche; Justin T Ward; Hani R Malone; Christopher Kellner; Samuel S Bruce; E Sander Connolly Journal: Neurosurgery Date: 2013-11 Impact factor: 4.654
Authors: Eric J Heyer; Christopher P Kellner; Hani R Malone; Samuel S Bruce; Joanna L Mergeche; Justin T Ward; E Sander Connolly Journal: J Neurosurg Date: 2013-05-10 Impact factor: 5.115
Authors: David R Goldsmith; Ebrahim Haroon; Bobbi J Woolwine; Moon Y Jung; Evanthia C Wommack; Philip D Harvey; Michael T Treadway; Jennifer C Felger; Andrew H Miller Journal: Brain Behav Immun Date: 2016-04-01 Impact factor: 7.217
Authors: Qinghai Liu; Shuhan He; Leonid Groysman; David Shaked; Jonathan Russin; Thomas C Scotton; Steven Cen; William J Mack Journal: PLoS One Date: 2013-12-30 Impact factor: 3.240